新疆维吾尔族肺癌患者初诊时癌痛情况调查分析

INVESTIGATION AND ANALYSIS OF CANCEROUS PAIN AMONG XINJIANG UGHUR PATIENTS WITH NEWLY DIAGNOSED LUNG CANCER

目的:通过对新疆肿瘤医院初诊的维吾尔族肺癌患者的临床基本特征及癌性疼痛(以下简称癌痛)进行统计分析,了解维吾尔族肺癌患者癌痛的发生率、疼痛情况及对疼痛的相关认知情况,为新疆地区维吾尔族肺癌患者的癌痛诊治提供可靠的临床资料。方法:收集并统计分析208例初次就诊的维吾尔族肺癌患者的年龄、性别、分期等基本信息,疼痛程度、部位、镇痛药物的使用情况以及对癌痛和镇痛药物认知情况等。结果:208例维吾尔族肺癌患者癌痛发生率为36.53%,晚期肺癌癌痛发生率合计41.32%,中重度癌痛合计占比54.65%,最主要的疼痛部位是胸部(27.63%)和肩背部(19.74%),服药率为57.89%,服用最多的药物为非甾体抗炎药,占癌痛患者27.63%,对疼痛及镇痛治疗及镇痛药物成瘾性认识存在诸多误区。结论:新疆地区维吾尔族肺癌患者就诊时伴发癌痛比率高,服药率低,疼痛控制情况差,对疼痛及止痛治疗认识不正确,对镇痛药物的成瘾性认识存在误区。应结合该民族文化心理特征对初诊患者进行癌痛相关知识的宣教,推进癌痛的规范化诊疗。

Objective： To investigate the incidence of cancerous pain and related pain cognition among Uygur patients with newly diagnosed lung cancer in Xinjiang Tumor Hospital,which would be helpful for diagnosis and treatment of cancerous pain. Methods： The clinical data of 208 newly diagnosed Uygur lung cancer patients, including age, gender, residence, stage, the degree and site of pain, analgesic drug and the cognition about analgesic drugs were collected and statistically analyzed. Results： The incidence of cancer pain in 208 cases of Uygur patients with lung cancer was 36.53%. A total incidence of cancer pain was 41.32% in advanced lung cancer. The moderate to severe cancer pain accounted for more than 54.65%. The main pain sites were located in the chest（27.63%）, shoulder and back（19.74%）. 57.89% of patients were taking painkillers. 27.63% of patients were taking non steroidal anti-inflammatory drugs, which was the most used analgesic drug. Misunderstanding on cancer pain, pain therapy and analgesic drug addiction widespreadly existed in these cases. Conclusions： There were a high ratio of cancer pain, low rate of taking medicine, and the dissatisfied pain treatment in Uygur patients. There were an incorrect understanding of cancer pain, pain treatment and analgesic drug addiction. Combined with the cultural and psychological characteristics, the knowledge related to cancer pain should be strengthened and to be introduced to the newly diagnosed patients, thus to promote the standardization of diagnosis and treatment of cancer pain.